Skip to main content

and
  1. Article

    Open Access

    Author’s Reply to Petersen: “Differences in In Vitro Properties of Pancreatin Preparations for Pancreatic Exocrine Insufficiency as Marketed in Russia and CIS”

    Igor V. Maev, Yury A. Kucheryavyy, Natalya B. Gubergrits, Ingo Bonnacker in Drugs in R&D (2021)

  2. Article

    Open Access

    Differences in In Vitro Properties of Pancreatin Preparations for Pancreatic Exocrine Insufficiency as Marketed in Russia and CIS

    Pancreatic enzyme-replacement therapy (PERT), provided as pancreatin to patients with pancreatic exocrine insufficiency (PEI), is considered an essential substitute for the pivotal physiological function the p...

    Igor V. Maev, Yury A. Kucheryavyy, Natalya B. Gubergrits, Ingo Bonnacker in Drugs in R&D (2020)